The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
New Antimalarial Drugs
Abstract
Approximately 40 % of the world population live in areas with the risk of malaria. Each year, 300–500 million people suffer from acute malaria, and 0.5–2.5 million die from the disease. Although malaria has been widely eradicated in many parts of the world, the global number of cases continues to rise. The most important reason for this alarming situation is the rapid spread of malaria parasites that are resistant to antimalarial drugs, especially chloroquine, which is by far the most frequently used. The development of new antimalarial drugs has been neglected since the 1970s owing to the end colonialism, changes in the areas of military engagement, and the restricted market potential. Only in recent years, in part supported by public funding programs, has interest in the development of antimalarial drugs been renewed. New data available from the recently sequenced genome of the malaria parasite Plasmodium falciparum and the application of methods of modern drug design promise to bring significant development in the fight against this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Rohmer, M., & Rohmer, M. (1999) · Natural Product Reports · doi:10.1039/a709175c · Cited by 1,193
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173
Self-citationWellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 807
Medical need, scientific opportunity and the drive for antimalarial drugs
Ridley, R. G. (2002) · Nature · doi:10.1038/415686a · Cited by 789
A Plastid of Probable Green Algal Origin in Apicomplexan Parasites
Köhler, S., Delwiche, C. F., Denny, P. W., Tilney, L. G., Webster, P., Wilson, R. J. M., Palmer, J. D., & Roos, D. S. (1997) · Science · doi:10.1126/science.275.5305.1485 · Cited by 760
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
Waller, R. F., Keeling, P. J., Donald, R. G. K., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A. F., Besra, G. S., Roos, D. S., & McFadden, G. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12352 · Cited by 714
Biochemistry of Plasmodium (malarial parasites)
Sherman, I. W. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.4.453-495.1979 · Cited by 639
Greenwood, B., & Mutabingwa, T. (2002) · Nature · doi:10.1038/415670a · Cited by 632
A plastid organelle as a drug target in apicomplexan parasites
Fichera, M. E., & Roos, D. S. (1997) · Nature · doi:10.1038/37132 · Cited by 585
Chemotherapy and drug resistance in malaria
Peters, W. (1970) · Medical Entomology and Zoology · Cited by 551
Fry, M., & Pudney, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90213-3 · Cited by 529
Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A. G., Rogerson, S. J., Lescano, A. G., Molyneux, M. E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338566 · Cited by 523
Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M., & Goldberg, D. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022630099 · Cited by 452
Surolia, N., & Surolia, A. (2001) · Nature Medicine · doi:10.1038/84612 · Cited by 412
In Vitro Antimalarial Activity of Chalcones and Their Derivatives
Li, R., Kenyon, G. L., Cohen, F. E., Chen, X., Gong, B., Dominguez, J. N., Davidson, E., Kurzban, G., Miller, R. E., Nuzum, E. O., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00026a010 · Cited by 409
Kuzuyama, T., Shimizu, T., Takahashi, S., & Seto, H. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01755-9 · Cited by 381
Arteether, a new antimalarial drug: synthesis and antimalarial properties
Brossi, A., Venugopalan, B., Dominguez Gerpe, L., Yeh, H. J. C., Flippen-Anderson, J. L., Buchs, P., Luo, X. D., Milhous, W., & Peters, W. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00398a026 · Cited by 320
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets
Coombs, G. H., Goldberg, D. E., Klemba, M., Berry, C., Kay, J., & Mottram, J. C. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02037-2 · Cited by 317
Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasites
Srivastava, I. K., Morrisey, J. M., Darrouzet, E., Daldal, F., & Vaidya, A. B. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01515.x · Cited by 310
A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil
Srivastava, I. K., & Vaidya, A. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1334 · Cited by 299
Ginsburg, H., Famin, O., Zhang, J., & Krugliak, M. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00184-1 · Cited by 287
4-Aminoquinolines—Past, present, and future; A chemical perspective
O'Neill, P. M., Bray, P. G., Hawley, S. R., Ward, S. A., & Park, B. K. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00084-3 · Cited by 282
Loria, P. M., Miller, S. K., Foley, M., & Tilley, L. M. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390363 · Cited by 272
Eggleson, K. K., Duffin, K. L., & Goldberg, D. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32411 · Cited by 267
Bhisutthibhan, J., Pan, X.-Q., Hossler, P. A., Walker, D. J., Yowell, C. A., Carlton, J., Dame, J. B., & Meshnick, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16192 · Cited by 263
Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in Vitro
Canfield, C. J., Pudney, M., & Gutteridge, W. E. (1995) · Experimental Parasitology · doi:10.1006/expr.1995.1049 · Cited by 247
Artemisinin and its derivatives: an important new class of antimalarial agents
Balint, G. A. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00140-1 · Cited by 244
Possible modes of action of the artemisinin-type compounds
Olliaro, P. L., Haynes, R. K., Meunier, B., & Yuthavong, Y. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(00)01838-9 · Cited by 228
White, N. J. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011721 · Cited by 226
Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C., & Pasvol, G. (2002) · Malaria Journal · doi:10.1186/1475-2875-1-1 · Cited by 225
Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines
Vennerstrom, J. L., Makler, M. T., Angerhofer, C. K., & Williams, J. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2671 · Cited by 223
Heme Degradation in the Presence of Glutathione
Atamna, H., & Ginsburg, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24876 · Cited by 216
Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria
Lell, B., Ruangweerayut, R., Wiesner, J., Missinou, M. A., Schindler, A., Baranek, T., Hintz, M., Hutchinson, D., Jomaa, H., & Kremsner, P. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.735-738.2003 · Cited by 216
Self-citationLooareesuwan, S., Chulay, J. D., Canfield, C. J., & Hutchinson, D. B. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.533 · Cited by 215
Perozzo, R., Kuo, M., Sidhu, A. B. S., Valiyaveettil, J. T., Bittman, R., Jacobs, W. R., Fidock, D. A., & Sacchettini, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112000200 · Cited by 213
Synthesis and Evaluation of Cryptolepine Analogues for Their Potential as New Antimalarial Agents
Wright, C. W., Addae-Kyereme, J., Breen, A. G., Brown, J. E., Cox, M. F., Croft, S. L., Gökçek, Y., Kendrick, H. D., Phillips, R. M., & Pollet, P. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010929+ · Cited by 199
The apicoplast as an antimalarial drug target
Ralph, S. A., D'Ombrain, M. C., & McFadden, G. I. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0205 · Cited by 198
Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics
R., H., S., W., & C., R. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-001-0918-z · Cited by 191
Ras—A Molecular Switch Involved in Tumor Formation
Wittinghofer, A., & Waldmann, H. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20001201)39:23<4192::aid-anie4192>3.0.co;2-y · Cited by 186
Zeidler, J., Schwender, J., Müller, C., Wiesner, J., Weidemeyer, C., Beck, E., Jomaa, H., & Lichtenthaler, H. K. (1998) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1998-11-1208 · Cited by 183
Self-citationMcGready, R., Cho, T., Keo, N. K., Thwai, K. L., Villegas, L., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Clinical Infectious Diseases · doi:10.1086/324349 · Cited by 178
A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes
Wengelnik, K., Vidal, V., Ancelin, M. L., Cathiard, A.-M., Morgat, J. L., Kocken, C. H., Calas, M., Herrera, S., Thomas, A. W., & Vial, H. J. (2002) · Science · doi:10.1126/science.1067236 · Cited by 178
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E., & Watkins, W. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06344-9 · Cited by 178
Lefèvre, G., Looareesuwan, S., Treeprasertsuk, S., Krudsood, S., Silachamroon, U., Gathmann, I., Mull, R., & Bakshi, R. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.64.247 · Cited by 178
Dunn, C. R., Banfield, M. J., Barker, J. J., Higham, C. W., Moreton, K. M., Turgut-Balik, D., Brady, R. L., & Holbrook, J. J. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-912 · Cited by 173
Fidock, D. A., Nomura, T., & Wellems, T. E. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1140 · Cited by 170
Shanks, G. D., Oloo, A. J., Aleman, G. M., Ohrt, C., Klotz, F. W., Braitman, D., Horton, J., & Brueckner, R. (2001) · Clinical Infectious Diseases · doi:10.1086/324081 · Cited by 168
Clindamycin as an Antimalarial Drug: Review of Clinical Trials
Lell, B., & Kremsner, P. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2315-2320.2002 · Cited by 166
An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery
Olliaro, P., & Yuthavong, Y. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00036-9 · Cited by 150
McKerrow, J. H. (1999) · International Journal for Parasitology · doi:10.1016/s0020-7519(99)00044-2 · Cited by 150
Farnesyl transferase inhibitors as anticancer agents
Haluska, P., Dy, G. K., & Adjei, A. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00166-1 · Cited by 149
Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum
Chakrabarti, D., da Silva, T., Barger, J., Paquette, S., Patel, H., Patterson, S., & Allen, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202860200 · Cited by 148
Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors
Olson, J. E. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00004-8 · Cited by 147
Taylor, W. R. J., Richie, T. L., Fryauff, D. J., Picarima, H., Ohrt, C., Tang, D. B., Braitman, D. J., Murphy, G. S., Widjaja, H., Tjitra, E., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515071 · Cited by 147
In Vitro and In Vivo Synergy of Fosmidomycin, a Novel Antimalarial Drug, with Clindamycin
Wiesner, J., Henschker, D., Hutchinson, D. B., Beck, E., & Jomaa, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2889-2894.2002 · Cited by 138
Self-citationVelankar, S. S., Ray, S. S., Gokhale, R. S., Suma, S., Balaram, H., Balaram, P., & Murthy, M. (1997) · Structure · doi:10.1016/s0969-2126(97)00230-x · Cited by 136
Malaria chemoprophylaxis with tafenoquine: a randomised study
Lell, B., Faucher, J., Missinou, M. A., Borrmann, S., Dangelmaier, O., Horton, J. D., & Kremsner, P. G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02352-7 · Cited by 135
Nzila, A. M., Nduati, E. W., Mberu, E. K., Sibley, C. H., Monks, S. A., Winstanley, P., & Watkins, W. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315520 · Cited by 134
Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war
Greenwood, D. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.5.857 · Cited by 131
Antimalarial Synergy of Cysteine and Aspartic Protease Inhibitors
Semenov, A., Olson, J. E., & Rosenthal, P. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2254 · Cited by 131
Progress with parasite plastids.
Wilson, R. J. M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00303-0 · Cited by 130
Davioud–Charvet, E., Delarue‐Cochin, S., Biot, C., Schwöbel, B., Boehme, C. C., Müssigbrodt, A., Maes, L. J. R. M., Sergheraert, C., Grellier, P., Schirmer, R. H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010268g · Cited by 129
Bahl, A., Brunk, B., Coppel, R. L., Crabtree, J., Diskin, S. J., Fraunholz, M. J., Grant, G. R., Gupta, D., Huestis, R. L., Kissinger, J. C., et al. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.87 · Cited by 128
Calas, M., Ancelin, M., Cordina, G., Portefaix, P., Piquet, G., Vidal-Sailhan, V., & Vial, H. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911027 · Cited by 127
Reuter, K., Sanderbrand, S., Jomaa, H., Wiesner, J., Steinbrecher, I., Beck, E., Hintz, M., Klebe, G., & Stubbs, M. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109500200 · Cited by 126
Self-citationPosner, G. H., Ploypradith, P., Parker, M. H., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990363d · Cited by 125
Malaria: New Developments in Treatment and Prevention
Newton, B. P., & White, N. J. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.179 · Cited by 125
The Artemether-Quinine Meta-analysis Study Group† (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90104-x · Cited by 125
Protein prenyl transferase activities of Plasmodium falciparum
Chakrabarti, D., Azam, T., DELVECCHIO, C., Qiu, L., Park, Y. I., & Allen, C. M. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(98)00065-6 · Cited by 119
Famin, O., Krugliak, M., & Ginsburg, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00059-3 · Cited by 119
Artemisinin drugs: novel antimalarial agents
Price, R. N. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1815 · Cited by 115
An Integrated Model of Chloroquine Action
Ginsburg, H., Ward, S. A., & Bray, P. G. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01502-1 · Cited by 111
Domínguez, J. N., López, S. E., Charris, J., Iarruso, L., Lobo, G., Semenov, A., Olson, J. E., & Rosenthal, P. J. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970266p · Cited by 107
Diaryl ester prodrugs of fR900098 with improved in vivo antimalarial activity
Reichenberg, A., Wiesner, J., Weidemeyer, C., Dreiseidler, E., Sanderbrand, S., Altincicek, B., Beck, E., Schlitzer, M., & Jomaa, H. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00075-0 · Cited by 106
Self-citationYajima, S., Nonaka, T., Kuzuyama, T., Seto, H., & Ohsawa, K. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003105 · Cited by 98
Mechanism of cardiotoxicity of halofantrine
WESCHE, D. L. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106127 · Cited by 90
O’Neill, P. M., Miller, A., Bishop, L. P. D., Hindley, S., Maggs, J. L., Ward, S. A., Roberts, S. M., Scheinmann, F., Stachulski, A. V., Posner, G. H., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000987f · Cited by 90
Malaria Chemoprophylaxis in the Age of Drug Resistance. I. Currently Recommended Drug Regimens
Kain, K. C., Shanks, G. D., & Keystone, J. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321817 · Cited by 89
Posner, G. H., Parker, M. H., Northrop, J. P., Elias, J. S., Ploypradith, P., Xie, S., & Shapiro, T. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980529v · Cited by 86
Vennerstrom, J. L., Dong, Y., Andersen, S. L., Ager, A. L., Fu, H., Miller, R. E., WESCHE, D. L., Kyle, D. E., Gerena, L., Walters, S. M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000766 · Cited by 84
Ginsburg, H., Nissani, E., & Krugliak, M. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90550-9 · Cited by 83
Famin, O., & Ginsburg, H. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00878-4 · Cited by 81
Curtis, J., Duraisingh, M. T., & Warhurst, D. C. (1998) · The Journal of Infectious Diseases · doi:10.1086/517831 · Cited by 79
Kurosawa, Y., Dorn, A., Kitsuji-Shirane, M., Shimada, H., Satoh, T., Matile, H., Hofheinz, W., Masciadri, R., Kansy, M., & Ridley, R. G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2638-2644.2000 · Cited by 78
Luo, X., Yeh, H. J. C., Brossi, A. R., Flippen-Anderson, J. L., & Gillardi, R. D. (1984) · Helvetica Chimica Acta · doi:10.1002/hlca.19840670615 · Cited by 77
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity
Ohkanda, J., Lockman, J. W., Yokoyama, K., Gelb, M. H., Croft, S. L., Kendrick, H. D., Harrell, M. I., Feagin, J. E., Blaskovich, M. A., Sebti, S. M., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00055-5 · Cited by 75
Kim, H., Certa, U., Döbeli, H., Jakob, P., & Hol, W. G. J. (1998) · Biochemistry · doi:10.1021/bi972233h · Cited by 74
Synthesis and Antimalarial Activity of Artemisinin Derivatives Containing an Amino Group
Li, Y., Zhu, Y., Jiang, H., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990552w · Cited by 73
Wyatt, D. M., & Berry, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02241-x · Cited by 71
Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents
Ohkanda, J., Knowles, D. B., Blaskovich, M. A., Sebti, S. M., & Hamilton, A. D. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394281 · Cited by 70
Alkylating Capacity and Reaction Products of Antimalarial Trioxanes after Activation by a Heme Model
Cazelles, J., Robert, A., & Meunier, B. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo010688d · Cited by 68
Severe allergic reactions to oral artesunate: a report of two cases
Leonardi, E., Gilvary, G., White, N. J., et al. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90157-9 · Cited by 66
Ras – ein molekularer Schalter bei der Tumorentstehung
Wittinghofer, A., & Waldmann, H. (2000) · Angewandte Chemie · doi:10.1002/1521-3757(20001201)112:23<4360::aid-ange4360>3.0.co;2-j · Cited by 66
Synthesis and in Vitro and in Vivo Antimalarial Activity of New 4-Anilinoquinolines
Delarue‐Cochin, S., Girault, S., Maes, L. J. R. M., Debreu‐Fontaine, M., Labaeïd, M., Grellier, P., & Sergheraert, C. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010842o · Cited by 64
In Vitro Activities of DU-1102, a New Trioxaquine Derivative, againstPlasmodium falciparumIsolates
Basco, L. K., Dechy‐Cabaret, O., Ndounga, M., Meche, F. S., Robert, A., & Meunier, B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1886-1888.2001 · Cited by 63
Posner, G. H., Jeon, H. B., Parker, M. H., Krasavin, M., Paik, I., & Shapiro, T. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102396 · Cited by 58
Posner, G. H., Cumming, J. N., Woo, S.-H., Ploypradith, P., Xie, S., & Shapiro, T. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970686e · Cited by 57
Chlorproguanil‐dapsone (LAPDAP) for uncomplicated falciparum malaria
Winstanley, P. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00751.x · Cited by 55
Gupta, S., Thapar, M. M., Mariga, S. T., et al. (2002) · Experimental Parasitology · doi:10.1006/expr.2001.4659 · Cited by 53
Ai, L., Zikry, A. B., & Kyle, D. E. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9607919 · Cited by 52
Girault, S., Grellier, P., Berecibar, A., Maes, L. J. R. M., Lemière, P., Mouray, E., Davioud–Charvet, E., & Sergheraert, C. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001096a · Cited by 45
New chemical and biological aspects of artemisinin-Derived trioxane dimers
Posner, G. H., Northrop, J. P., Paik, I., Borstnik, K., Dolan, P., Kensler, T. W., Xie, S., & Shapiro, T. A. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00270-x · Cited by 42
Therapeutic responses to antibacterial drugs in vivax malaria
Pukrittayakamee, S., Clemens, R. L., Chantra, A., Nontprasert, A., Luknam, T., Looareesuwan, S., & White, N. J. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90027-6 · Cited by 35
Plasmodium falciparum: Detection of the Deoxyxylulose 5-Phosphate Reductoisomerase Activity
Wiesner, J., Hintz, M., Altincicek, B., Sanderbrand, S., Weidemeyer, C., Beck, E., & Jomaa, H. (2000) · Experimental Parasitology · doi:10.1006/expr.2000.4566 · Cited by 33
Self-citationAntifolate drug resistance and point mutations in Plasmodium falciparum in Kenya
Khan, B., Omar, S. A., Kanyara, J. N., Warren-Perry, M., Nyalwidhe, J. O., Peterson, D. S., Wellems, T. E., Kaniaru, S., Gitonga, J. N., Mulaa, F. J., et al. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90284-4 · Cited by 29
Interference with Heme Binding to Histidine-Rich Protein-2 as an Antimalarial Strategy
Choi, C. Y. H., Schneider, E. L., Kim, J. M., et al. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00183-7 · Cited by 25
Novel and Potent Anti-malarial Agents
Brinner, K. M., Kim, J., Habashita, H., Gluzman, I. Y., Goldberg, D. E., & Ellman, J. A. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00207-9 · Cited by 22
Wiesner, J., Mitsch, A., Wißner, P., Krämer, O., Jomaa, H., & Schlitzer, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00555-3 · Cited by 16
Self-citation
Cited by
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
Solomon, V. R., & Lee, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.063 · Cited by 516
Biologically active quinoline and quinazoline alkaloids part I
Shang, X., Morris‐Natschke, S. L., Liu, Y., Guo, X., Xu, X., Goto, M., Li, J., Yang, G., & Lee, K. (2018) · Medicinal Research Reviews · doi:10.1002/med.21466 · Cited by 437
Primaquine revisited six decades after its discovery
Vale, N., Moreira, R., & Gomes, P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.08.011 · Cited by 367
Yang, B., Ding, L., Yao, H., Chen, Y., & Shi, J. (2020) · Advanced Materials · doi:10.1002/adma.201907152 · Cited by 360
Krauth‐Siegel, R. L., Bauer, H., & Schirmer, R. H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200300639 · Cited by 302
Metadata
- Authors
- Wiesner, J., Ortmann, R., Jomaa, H., & Schlitzer, M.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2003-11-04
- Volume
- 42
- Issue
- 43
- Pages
- 5274-5293
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W1995064146
- Cited by
- 428
- References
- 110
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.